Patent · US Active

Adenocarcinoma specific antibody SAM-6, and uses thereof

US8741296B2 · kind B2 · utility

1Cited by

11References

16Claims

0Family size

Assignee

Patrys Limited · AU

Inventors

Heinz Peter Vollmers · Coburg, DE
Hans-Konrad Muller-Hermelink · Würzburg, DE

Key dates

Filing date	Mar 23, 2012
Grant date	Jun 3, 2014
Priority date	—
Expiry date	Mar 23, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.